BeStock  
Stocks › Biotechnology › INCY

Incyte INCY

US equityMarket cap rank #824BiotechnologyCAR-T Therapy
$114.63 −$1.25 (-1.07%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $114.63 0.00%
Open$116.85
Prev close$115.87
Day range$114.28 – $117.51
Volume1.54M
Market cap$23.36B
P/E (TTM)58.5
Dividend yield–

Analyst view

ConsensusBuy
Analysts17
Average target$136.65+19.2% vs. price
  • Buy 59%
  • Hold 41%
Low $115.00Now $114.63Avg $136.65High $157.00

Recent rating changes

The last 20 actions on file set price targets from $127.00 to $157.00, averaging $143.55.

DateFirmRatingTarget
19 Nov 2026 Leerink Partners BUY $148.00
17 Nov 2026 CCORF BUY $152.00
17 Nov 2026 H.C. Wainwright BUY $152.00
16 Nov 2026 Piper Sandler BUY $130.00
16 Nov 2026 BMO Capital HOLD $130.00
13 Nov 2026 BofA Securities BUY $143.00
5 Nov 2026 CCORF BUY $152.00
5 Nov 2026 Leerink Partners BUY $150.00
5 Nov 2026 H.C. Wainwright BUY $152.00
2 Nov 2026 BofA Securities BUY $143.00
2 Nov 2026 BMO Capital HOLD $130.00
2 Nov 2026 H.C. Wainwright BUY $152.00
30 Oct 2026 CCORF BUY $152.00
30 Oct 2026 UBS HOLD $127.00
30 Oct 2026 Evercore HOLD $127.00
30 Oct 2026 Stifel BUY $157.00
30 Oct 2026 H.C. Wainwright BUY $152.00
30 Oct 2026 Barclays BUY $143.00
29 Oct 2026 Wells Fargo HOLD $127.00
29 Oct 2026 Guggenheim BUY $152.00

Discussion

No comments yet — be the first to weigh in on INCY.

Sign in to join the discussion.

Scroll to Top